CurvaFix, Inc., a developer of devices for repairing fractures in curved bones, has received US FDA 510(k) clearance for its new CurvaFix® Low Profile System.
This percutaneous device is designed to stabilise pelvic fractures, which affect an estimated 200,000 people annually in the United States. Surgical fixation can restore stability, reduce pain and support early mobility, which is key to recovery and quality of life.
The Low Profile System builds on four years of clinical use and thousands of successful implants. It is designed to simplify implantation while addressing the complex anatomy of the pelvis and enabling easier implant removal when needed.
The system expands treatment options for difficult surgical cases, including pathological bone, curved or narrow pelvic corridors, intersecting fixation pathways and situations involving existing hardware.
It features a 65 per cent smaller head geometry for a lower-profile implant, increased compression capability, and implant lengths up to 210 mm to connect intraosseous fixation pathways with a single device.
It also incorporates patented locking technology with enhanced visual and tactile confirmation.
CurvaFix technology is intended to follow the natural curvature of the pelvis, providing strong and stable fixation.
This approach may reduce pain, allow earlier weight-bearing and improve recovery compared with conventional straight implants.
